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Introduction
Pneumothorax is a well recognised complication in AIDS, primarily in patients with Pneumocystis carinii pneumonia (PCP) .1A8 Other reported associations include the use of nebulised pentamidine.45 Because of the recalcitrant nature of pneumothorax in a high proportion of patients, and the consequent failure of conservative measures, decisions frequently need to be made about whether to persist with medical therapies or to intervene surgically. Although surgical intervention is known to achieve success in these circumstances9 opinion still varies as to how appropriate such procedures may be.'0 In this report we review our experience of pneumothorax in 15 patients with AIDS and propose a clinical approach to intervention.
Patients and methods
Within our unit all patients diagnosed as being HIV1 antibody positive have records of their personal history and subsequent HIV care entered upon the departmental computer. From these records for the period between 1988-1992 we identified 15 patients who developed one or more pneumothoraces during the course of their illness. To our knowledge casefinding was complete. On review of the case notes we extracted information regarding demographic characteristics, CD4 count, PCP prophylaxis, and the history, investigation and outcome of each event.
On the diagnosis of pneumothorax, our standard practice initially was to assess the patient to ascertain whether observation or aspiration would be feasible for that individual. If intercostal drainage was required, a chest drain was inserted with an underwater seal and suction of 5-10 mm water applied.
When air leakage ceased the drain was removed. In those cases with persistent leakage, chemical pleurodesis was consideredeither with tetracycline or Corynebacterium parvum.
Failure of medical treatment was the indication for surgical intervention. Posterolateral thoracotomy or median sternotomy was performed to deal with unilateral or bilateral pneumothorax respectively. Complete pleurectomy was the standard procedure; additional methods being used selectively to deal with large air leaks.
Results
Over the period of study there were 15 patients who experienced pneumothorax. None of these cases were precipitated by mechanical ventilation. Of the 15, three were iatrogenic-following pleural aspiration (n = 1) and transbronchial biopsy (n = 2). All three responded within seven days to conventional medical therapy-one without intervention; the other two requiring intercostal In the group of six patients who had pneumothorax successfully dealt with medically, median time spent on intercostal drainage was 8.5 days (although two of this group did eventually require surgery). This contrasts with the group who proceeded to surgery, failing medical therapy after a median 22 days intercostal drainage. Six out of the seven patients operated on, were alive three months following surgery with median survival of 310 days.
Discussion
This study confirms the significant association of pneumothorax with PCP in AIDS. Previous reports suggest an incidence of pneumothorax in 6-9% of patients with PCP.78 As PCP remains one of the most common opportunistic infections seen in such individuals this represents a substantial contribution to morbidity. In addition to a past history seen in the majority, all patients had evidence to suggest intercurrent PCP. Although the numbers are too small to draw firm conclusions it is possible that pneumothorax is associated with active PCP rather than existing lung damage from previous episodes.
One third of the patients were using nebulised pentamidine during the period immediately preceding the pneumothorax. In our unit, over the time period studied, 28% of patients considered at risk of developing PCP used nebulised pentamidine as their prophylactic agent. Although this does not support the assertion of other authors that the use of nebulised pentamidine is associated with a higher risk of pneumothorax, it is our policy not to recommend this form of prophylaxis after pneumothorax has occurred.
The time spent on intercostal drainage was short for those patients in whom this procedure was sufficient for resolution. Whilst for those who proceeded to surgery it is not possible to know whether prolonged intercostal drainage would have resulted in resolution, we speculate that these were true medical failures. With a median 22 days on drainage before opting for surgery, we believe a reasonable medical trial was given. The Pneumothorax is a significant complication in AIDS patients. Following the association with intercurrent Pneumocystis carinii infection we would suggest that in all immunosuppressed HIV positive patients with spontaneous pneumothorax there be a high diagnostic suspicion of active PCP. Those patients with an iatrogenic or a single, unilateral pneumothorax would be expected to respond to conventional medical therapy, and therefore should be managed in much the same way as a non HIV infected patient. It is important that the initial medical management is optimised, by the use of a large bore intercostal tube (or tubes) and suction. We have identified patients with bilateral or recurrent pneumothorax as a group in whom early referral for thoracic surgery may be beneficial. In this patient group we confirm surgery is both successful in the short term and considering the circumstances associated with reasonable survival, though it would be worthwhile confirming this with prospective evaluation of a management protocol. We do not believe that HIV positivity and immunosuppression in themselves should be considered contraindications to surgery.
